Change in number of shares and votes in Aerocrine

Before you go, we thought you'd like these...
Before you go close icon

Change in number of shares and votes in Aerocrine

SOLNA, Sweden--(BUSINESS WIRE)-- Regulatory News:

With reference to Chapter 4 Section 9 in "lagen (1991:980) om handel med finansiella instrument" it's hereby announced that through the subscription by exercise of options in Aerocrine the number of shares and votes in Aerocrine has increased during August 2012 as specified in the table below.

   Number of shares and votes
August 1, 2012144 947 999
Increase299 510
August 31, 2012145 247 509

Solna October 31, 2012

Aerocrine AB (publ.)

About Aerocrine

Aerocrine AB (STO:AERO-B) is a medical technology company focused on the improved management and care of patients with inflammatory airway diseases. The pioneer and leader in the technology to monitor and manage airway inflammation, Aerocrine markets NIOX MINO® and NIOX® Flex. Both products enable the fast and reliable measurement of airway inflammation and may thus play a critical role in more effective diagnosis, treatment and follow-up of patients with inflammatory airway diseases such as asthma. Aerocrine is based in Sweden with subsidiaries in the US, Germany and the UK. Aerocrine shares were listed on the Stockholm Stock Exchange on 15 June 2007.

------------------------------------------------------------------------------

Aerocrine may be required to disclose the information provided herein pursuant to the Securities Markets Act and/or the Financial Instruments Trading Act. The information was submitted for publication at 08:00 am on October 31, 2012.

------------------------------------------------------------------------------

This information was brought to you by Cision http://www.cisionwire.com



Michael Colérus, CFO, +46 8 629 07 85

KEYWORDS:   Europe  Sweden

INDUSTRY KEYWORDS:

The article Change in number of shares and votes in Aerocrine originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story

Want more news like this?

Sign up for Finance Report by AOL and get everything from business news to personal finance tips delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.

From Our Partners